Singapore 2025

 

Cell Fate and its Regulation in Health and Disease
The International Cell Death Society Presents
Organizers:

Marie Veronique Clément    Richard A. Lockshin   Shazib Pervaiz   Zahra Zakeri  

 

May 28-30, 2025

Yong Loo Lin School of Medicine, National University of Singapore

 

11:00am – 12:45pm Registration

ICDS 2025 MCs:  Marie-Veronique CLEMENT (Singapore)  and Shan J.A. PERVAIZ (France)

12:45pm – 1:00pm

 

 

 

 

Opening Address by Co-Chairs of ICDS 2025

Zahra ZAKERI* and Shazib PERVAIZ#

*Professor Emerita, Queen’s College Department of Biology, City University of New York, NY, USA

#Professor, Department of Physiology and NUS Centre for Cancer Research, YLL School of Medicine, National University of Singapore (NUS), Singapore

Award Lectures Chaired by: Marie-Veronique CLEMENT, Singapore
1:00pm – 1:15pm Marie HARDWICK, USA, presenting Jerry Chipuk on behalf of Richard LOCKSHIN, USA
1:15pm – 2:00pm Award Lecture 1 (Keynote 1)

Jerry CHIPUK, USA

Precisely 1.5 – 2 billion years of mitochondrial control in cell death decisions

Director of Cell Biology, Icahn School of Medicine, Mount Sinai, USA

2:00pm – 2:15pm Raymond BIRGE, USA, presenting Shazib Pervaiz
2:15pm – 3:00pm Award Lecture 2 (Keynote 2)

Shazib PERVAIZ, Singapore

The Radical Biology of Oxygen in Cancer Cell Fate Signaling
Professor, Department of Physiology and NUS Centre for Cancer Research, YLL School of Medicine, NUS, Singapore

3:00pm – 3:20pm Presentation of Awards

Marie-Veronique CLEMENT to invite Raymond BIRGE (USA) and Marianne CRONJE (South Africa) for presentation of ICDS lifetime achievement awards

3:20pm – 3:45pm COFFEE/TEA BREAK
SESSION  1

(Day 1)

Theme: Cell Fate and Immunity

Chaired by: Ann-Marie CHACKO, Singapore

Assistant Professor, Duke-NUS Graduate Medical School, Singapore

3:45pm – 4:15pm Dmitri KRYSKO, Belgium

Ferroptosis-armed dendritic cells for glioma immunotherapy

Professor, Faculty of Medicine and Health Sciences, Ghent University, Belgium

4:15pm – 4:45pm Raymond BIRGE, USA

Targeting phospholipid scramblase and phosphatidylserine externalization in the cancer microenvironment
Professor, Rutgers Health, Cancer Institute of New Jersey, NJ, USA

4:45pm – 5:15pm Marc DIEDERICH, South Korea

Harnessing controlled necrosis for immunogenic vaccination against myeloid Leukemia

Professor, Department of Pharmacy, Seoul National University, Seoul, S. Korea

END OF DAY 1

 

29th May 2025, Thursday

SESSION  2

(Day 2)

Theme: Signaling Pathways in Cell Fate

Chaired by: Reshma TANEJA, Singapore

Professor and Head, Department of Physiology, YLL School of Medicine, NUS, Singapore

9:00am – 9:30am Seamus MARTIN, Ireland

DNA damage-induced cell death versus cell senescence: What doesn’t kill you, makes you stranger

Professor, Department of Genetics, Trinity College, Dublin, Ireland

9:30am – 10:00am Barbara CONRADT, UK

Revisiting how the C. elegans apoptosis pathway is activated

Professor and Head, Department of Cell & Developmental Biology, University College London, England, UK

10:00am – 10:30am Kanaga SABAPATHY, Singapore

p53 isoforms in cancer and fertility

Professor and Chair, School of Biological Sciences, Nanyang Technological University (NTU), Singapore

10:30am – 10:45am Yinghui LI, Singapore – Short Talk

TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes metastasis in triple-negative breast cancer

Assistant Professor, School of Biological Sciences, NTU, Singapore

10:45am – 11:05am COFFEE/TEA BREAK
SESSION 3

(Day 2)

Theme: Mitochondrial Metabolism and Cell Fate
Chaired by: Thilo HAGEN, Singapore

Associate Professor, Department of Biochemistry, YLL School of Medicine, NUS, Singapore

11:05am – 11:35am Stephen CHONG, Singapore

Targeting the phosphorylation of Bcl-2 family members in venetoclax-resistant hematologic malignancies

LKY Research Fellow, Department of Physiology, YLL School of Medicine, NUS, Singapore

11:35am – 12:05pm Dhyan CHANDRA, USA

Mitochondrial unfolded protein response-dependent survival signaling promotes neuroendocrine prostate cancer

Professor, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

12:05pm – 12:35pm Marie HARDWICK, USA

Regulation of the mitochondrial ATP synthase by BCL-xL

Professor, Bloomberg School of Public Health, School of Medicine, Johns Hopkins University, USA

Flash Talks 1 Chaired by:  Claudia CERELLA, Luxembourg

Principal Investigator, Laboratoire de Biologie Moleculaire et Cellulaire du Cancer, Luxembourg

12:35pm – 12:50pm 3 Flash Talks selected from Abstracts
12:50pm – 2:00pm Lunch
Session 4

(Day 2)

Theme: Stress Response Signaling in Cell Fate
Chaired by: Sharad KUMAR, Australia
Chair, Centre of Cancer Biology, University of South Australia, Adelaide, Australia
2:00pm – 2:30pm Anne-Sophie ARMAND, France

Role of GPRC6A expressing cells in human prostate cancer
Principal Investigator, Institut Necker Enfants Malades, Paris, France

2:30pm – 3:00pm Samuel KATZ, USA

The BCL-2 family member BOK regulates neuronal cell fate

Associate Professor, Department of Pathology, Yale School of Medicine, New Haven, CT, USA

3:00pm – 3:15pm John CHUA, Singapore – Short Talk

Proteomic analyses of early brain proteome alterations in Alzheimer’s disease

Assistant Professor, Department of Physiology, YLL School of Medicine, NUS, Singapore

3:15pm – 3:30pm Eli ARAMA, Israel – Short Talk

The Initiator Caspase Drives Compensatory Proliferation During Epithelial Tissue Regeneration After Ionizing Radiation

Professor, Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

3:30pm – 5:30pm Poster Session and Coffee/Tea Break          
6:30pm – 9:30pm Gala Dinner (By Invitation only)
 END OF DAY 2

 

30th May 2025, Friday

SESSION  5

(Day 3)

Theme: Cell Fate in Oncogenesis and Cancer Therapy
Chaired by: Alan Prem KUMAR, Singapore

Assistant Professor, Department of Pharmacology, YLL School of Medicine, NUS, Singapore

9:00am – 9:30am Marie ARSENIAN-HENRIKSSON, Sweden

Metabolic reprogramming by MYC inhibition as precision medicine in childhood neuroblastoma and clear cell renal carcinoma

Professor, Department of Molecular Tumor Biology, Karolinska Institutet, Stockholm, Sweden

9:30am – 10:00am Alessandro CARRER, Italy

Cholesterol homeostasis tunes cellular sensitivity to ferroptosis

Group Leader, Veneto Institute for Molecular Medicine, Padua, Italy

10:00am – 10:15am Mengge YU, Singapore – Short Talk

The BIM deletion polymorphism: Dissecting its role in leukemic stem cell survival and therapeutic response

Research Fellow, Duke-NUS Medical School, Singapore

10:15am – 10:30am Ying Yu LIANG, Singapore Short Talk

Capturing the dynamic interactome during cell death and drug-induced resistance mechanisms using time resolved MS-CETSA

Research Fellow, IMCB, ASTAR, Singapore

10:30am – 10:50am Coffee/Tea Break
SESSION  6

(Day 3)

Theme: Therapeutic Targets in Cancer Cell Fate Signalling
Chaired by: Marianne CRONJE, South Africa

Professor and Head, School of Molecular & Cell Biology, University of the Witwatersrand, Johannesburg, South Africa

10:50am – 11:20am Derrick ONG Sek Tong, Singapore

Uncovering novel glioblastoma dependencies for mechanism-guided therapies
Assistant Professor, Department of Physiology, YLL School of Medicine, NUS, Singapore

11:20am – 11:50am Boon Cher GOH, Singapore

Tumor derived extracellular vesicles are biologically active as cell-cell communicators

Professor, Cancer Science Institute and Department of Pharmacology & Department of Medicine, YLL School of Medicine, NUS/NUHS, Singapore

11:50am – 12:20pm Shruti BHATT, Singapore

Rewiring apoptosis: A new therapeutic window for TP53-mutant cancers
Assistant Professor, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, NUS, Singapore

12:20pm – 12:35pm Chit Fang CHEOK, Singapore – Short Talk

Mechanism of fork remodelling:  insights into therapeutic targeting
Assistant Professor, Department of Pathology, Yong Loo Lin School of Medicine, NUS, Singapore

12:35pm – 2:10pm Lunch and Poster Session
ICDS Board Meeting
SESSION  7

(Day 3)

Theme: Cell Fate in Homeostasis and Disease Response
Chaired by: Lih Wen DENG

Associate Professor, Department of Biochemistry and N2CR, YLL School of Medicine, NUS, Singapore

2:10pm – 2:40pm Franck OURY, France

Hypothalamic control of cognition and aging

Principal Investigator, Institut Necker Enfants Malades, Paris, France

2:40pm – 3:10pm Ali SHAZIB, USA

Fate in programmed death signaling- oral events associated with immune checkpoint inhibitors
Dean and Associate Professor, Workman School of Dentistry, Highpoint University, Highpoint, NC, USA

3:10pm – 3:25pm Yunus AKKOC, Turkey – Short Talk

The Role of Autophagy in the Tumor Microenvironment

Research Fellow, Department of Basic Medical Sciences, Koç University, Istanbul, Turkey

Flash Talks 2 Chaired by: Karen Carmelina CRASTA, Singapore

Research Assistant Professor, NUS Healthy Longevity Program and Department of Physiology, YLL School of Medicine, NUS, Singapore

 

3:25pm – 3:40pm 3 Flash Talks selected from Abstracts
3:40pm – 4:00pm Tea Break
SESSION  8

(Day 3)

Theme: Cell Fate in Age-Related Disorders
Chaired by: Tugba Bagci ONDER, Turkey

Professor, Graduate School of Health Sciences, Koç University, Istanbul, Turkey

4:00pm – 4:15pm Andreas BERGMANN, USA – Short talk

Mechanism of apoptosis-induced proliferation in Drosophila

Professor, Department of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, USA

4:15pm – 4:30pm Naiyang FU, Australia – Short Talk

MCL1 safeguards activated hair follicle stem cells to enable adult hair regeneration

Principal Investigator, WEHI of Medical Research, Melbourne, Australia

4:30pm – 5:00pm Mick LEE, Singapore

Understanding cardiomyocyte cell fate and gene regulation in the heart 

Research Fellow, Cardiovascular Research Institute, NUS, Singapore

5:00pm – 5:30pm Brian KENNEDY, Singapore

The Longevity Revolution

Professor, NUS Healthy Longevity Program and Departments of Biochemistry & Physiology, YLL School of Medicine, NUS, Singapore

5:30pm – 5:45pm Awards and Closing Remarks
End of Day 3

 

 

Awardees:

Jerry Edward Chipuk

Although our awardee, Jerry Edward Chipuk, described his approach, in a wonderful interview in the Journal of Cell Biology[1], as “My approach is to complete goals one at a time, and not distract myself by worrying about the lists of items to complete,” many of his friends and colleagues would venture that “Everything, Everywhere, All At Once,” might be a  better description. Jerry represents the new generation of scientists, strongly focused on a central point of cell biology—the mitochondrion—and asking the extent of mitochondrial involvement in everything. Thus, while he is Associate Director of Shared Resources at the Tisch Cancer Institute of Mt. Sinai School of Medicine, he is also associated with the Department of Oncological Sciences, the Department of Dermatology, the Diabetes, Obesity, and Metabolism Institute, and the Mitochondrial Analysis Facility. As a new-generation scientist, he reaches into several highly technical worlds beyond basic biochemistry, cell biology, or biophysics, such as high- and ultra-resolution microscopy, using fluors and other traceable molecules along with the most modern means of data mining and structural analysis to follow the number, shape, polarization, fusion and fission, and life and death of mitochondria in many types of cancer and other diseases. A quick perusal of the titles of the over 80 papers he has authored or co-authored reveals the diversity of his interests and gives a glimpse into the new vision of how mitochondria react to and control key moments in the lives of cells, as expressed by his professed interests in mitochondrial dynamics, cancer mechanisms, and melanocyte biology. Based on his work, this generation of scholars sees mitochondria not as neatly arrayed collection of membranes that the early electron microscopists saw, but as living creatures, transporting and binding materials, actively moving, and in many senses determining how a cell lives or dies[2],[3]. His ability to maintain a sense of the importance of an astonishing array of techniques and devices is an inspiration.

Gerry’s catholic interests and love of travel have led him also to build a highly original and fascinating collection of artworks and artifacts from around the world. That collection bespeaks his approach to research, and why we honor him today: Ask everything, never be afraid to explore further, well into territories you do not yet know, examine it carefully and critically, but with empathy and love. It is a lifestyle that all of us can admire.

[1] O’Donnell MA  and Infarinato N,  Jerry Chipuk: A powerhouse for mitochondrial biology. J. Cell Biol. 2018 Vol. 217 No. 8 2599–2600, https://doi.org/ 10.1083/ jcb.201807034

[2]  Chipuk JE,  Mohammed J N,  Gelles J D,  Chen Y 2021, Mechanistic connections between mitochondrial biology and regulated cell death. Dev Cell. 2021:1221–1233. doi: 10.1016/j.devcel.2021.03.033

[3]  Pucadyil T J,  Chipuk J E,  Liu Y, O’Neill L, Chen Q, 2023. The multifaceted roles of mitochondria Mol Cell. 2023 Mar 16;83(6):819–823. doi: 10.1016/j.molcel.2023.02.030

 

SHAZIB PERVAIZ

On behalf of Drs. Zahra Zakeri and Richard Lockshin, and the Board of Directions of the international Cell Death Society (ICDS), it is my great pleasure to present the 2025 ICDS Prize to Professor Shazib Pervaiz, for his outstanding contributions to field of Cell Death over the past 3+ decades.

 

Shazib, a native of Pakistan, received his BS degree from King Edward Medical College, Lahore in 1984 before emigrating to the US to complete a PhD from Southern Methodist University in Dallas and postdoctoral training from Harvard Medical School and Mass General Hospital in Boston.

 

It was during his postdoctoral work that Shazib became interested in cell death, exploring how T cells kill tumor cells and the role of novel cytokines in the differentiation of T helper cells.

After his training at Harvard, Shazib migrated to NUS in Singapore where has been on the faculty for almost 30 years, achieving rank of  Full Professor, Senior Faculty to the NUS Graduate School for Integrative Sciences and Engineering, and previously Deputy Director of the NUS Medical Institutes.  He has numerous research, teaching, and academic awards, and visiting scientist positions all over the world, including in the United States, France, China, and Australia.

Over the last 30 years, Shazib has developed a bold, and–somewhat true to his nature–adventurous research program that at times challenges and questions dogmas.  With a focus on redox signaling and biology in cancer development, his laboratory has elegantly shown that reactive oxygen species, and a pro-oxidant state, can foster adaptations in cancer cells that result in drug resistance.  His lab has discovered many key signaling pathways in ROS adapted tumor cells, including how ROS targets kinases and phosphatases (the latter having active cysteine residues in the catalytic site) and how ROS impinges on Bcl-2 and mitochondrial/caspase -mediated cell death.  He and his colleagues have defined new terminologies of Onco-ROS and Tumor Suppressor ROS that are applicable to a wide range of cancers. His more recent work identifying compounds that target mutant KRAS (the gene that makes K-Ras, Kirsten Rat Sarcoma protein) to super-activate ROS are poised to contribute to a new class of targeted therapeutics.  Since KRAS is very frequently mutated in colorectal and several other cancers, the ability to induce only the mutant cells to activate death pathways would be a much less toxic and very promising therapeutic advance.

In addition to his wonderful science, Shazib is passionate for life’s adventures.   He is a competitive athlete and a certified life coach, who strongly believes in the remarkable power of human spirit and introspection.  Incidentally, Shazib won second place in his age-group at the AACR 5K run in Chicago, and as a researcher is figuratively running well ahead of his competition.  On behalf of the ICDS and the ICDS Board of Trustees, it is our great pleasure to present you the 2025 ICDS Prize for outstanding contributions to Cell Death.

 

IN MEMORIAM: JOHN FOXTON ROSS KERR

Kerr, Wyllie, and Currie 19721 is a classic paper that should be on the reading list of cell biology classes worldwide. Likewise, an obituary in Cell Death and Differentiation2 sums John Kerr’s admirable career as a founder of the field.

It is also worth reflecting on the man that John Kerr was.

He wrote in an era before social media and even Microsoft Word offer to compose all our thoughts. John had been writing about “shrinkage necrosis” for several years, but the term “apoptosis” was elegant and eloquent. Not only did the word imply universality, but it also captured the sense that cell death was the end of a universal cycle that began with mitosis, and that cell death was as important and as worthy of study as the beginning. Thus, that paper launched a generation of researchers.

It was also typical of John the individual: precise, profound, thoughtful, gentle, diffident and caring; meticulous in detail as he collected regional variants of Lepidoptera so that we could better understand the mechanics of how evolution worked; gentle and loving with Maureen, and considerate to everyone he met. That was how he was when Zahra and I first met him in Sardinia in 1989, and every other time that we encountered him. Sharad Kumar shares that he typically hand-wrote letters of congratulations to national colleagues. He is an exemplar of why students should learn about the lives of scientists and not just their work. We will cherish his memory.

John F R Kerr (Contributed by Maureen Field Kerr); letter from John Kerr to Sharad Kumar (contributed by Sharad Kumar).

 

1Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972 Aug;26(4):239-57. doi: 10.1038/bjc.1972.33. PMID: 4561027; PMCID: PMC2008650.

2Cummings, M.C., Vaux, D.L., Strasser, A. et al. John F. R. Kerr (1934–2024). Cell Death Differ 31, 955–956 (2024). https://doi.org/10.1038/s41418-024-013

.